Global partners converged on a shared concern: development assistance for health is projected to fall by nearly 50% between 2021 and 2030, placing acute pressure on African countries where external funding covers more than a third — and in some cases more than half — of health expenditures. Gavi reaffirmed its commitment to HPV vaccination, noting board-level affirmation of the investment case and forthcoming lower-cost vaccine options through market shaping. The World Bank highlighted that its demand-driven lending model means increased HPV support depends on ministries of finance actively requesting it, and flagged poor budget execution — in some countries as low as 50% of health budgets — as a barrier to future allocations. The Gates Foundation positioned itself as a catalytic funder focused on cost-effective delivery research, reaching out-of-school girls, and translating learning into action. All three agencies endorsed a collective action framing — summarised by the moderator as Collective action, Engagement, and Operational efficiency — as the path to sustaining HPV programmes through the current financing transition.